scispace - formally typeset
Open AccessJournal ArticleDOI

Oral Inflammatory Diseases and Systemic Inflammation: Role of the Macrophage

Reads0
Chats0
TLDR
The objective is to identify macrophage-mediated events central to the inflammatory basis of chronic diseases, with an emphasis on how control of macrophages function can be used to prevent or treat harmful outcomes linked to uncontrolled inflammation.
Abstract
Inflammation is a complex reaction to injurious agents and includes vascular responses, migration, and activation of leukocytes. Inflammation starts with an acute reaction, which evolves into a chronic phase if allowed to persist unresolved. Acute inflammation is a rapid process characterized by fluid exudation and emigration of leukocytes, primarily neutrophils, whereas chronic inflammation extends over a longer time and is associated with lymphocyte and macrophage infiltration, blood vessel proliferation, and fibrosis. Inflammation is terminated when the invader is eliminated, and the secreted mediators are removed; however, many factors modify the course and morphologic appearance as well as the termination pattern and duration of inflammation. Chronic inflammatory illnesses such as diabetes, arthritis, and heart disease are now seen as problems that might have an impact on the periodontium. Reciprocal effects of periodontal diseases are potential factors modifying severity in the progression of systemic inflammatory diseases. Macrophages are key cells for the inflammatory processes as regulators directing inflammation to chronic pathological changes or resolution with no damage or scar tissue formation. As such, macrophages are involved in a remarkably diverse array of homeostatic processes of vital importance to the host. In addition to their critical role in immunity, macrophages are also widely recognized as ubiquitous mediators of cellular turnover and maintenance of extracellular matrix homeostasis. In this review, our objective is to identify macrophage-mediated events central to the inflammatory basis of chronic diseases, with an emphasis on how control of macrophage function can be used to prevent or treat harmful outcomes linked to uncontrolled inflammation.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Pathologic Basis of Disease

Nelson R. Niles
- 23 Sep 1974 - 
TL;DR: A great strength of the subject of pathology is that it bonds strongly with many other medical sciences and specialties and thus occupies the top spot in the field.
Journal ArticleDOI

Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations

TL;DR: This review will discuss a wide range of evolving data leading to the current hypotheses regarding the role of immune activation and inflammation in OA onset and progression as this is the joint most well characterized by epidemiologic, imaging, and translational studies investigating the association of inflammation with OA.
Journal ArticleDOI

Activation and resolution of periodontal inflammation and its systemic impact.

TL;DR: A new treatment concept in which natural pathways of resolution of periodontal inflammation can be used to limit systemic inflammation and promote healing and regeneration is discussed.
References
More filters
Journal ArticleDOI

The pathogenesis of atherosclerosis: a perspective for the 1990s

TL;DR: The ability to control the expression of genes encoding these molecules and to target specific cell types provides opportunities to develop new diagnostic and therapeutic agents to induce the regression of the lesions and, possibly, to prevent their formation.
Journal ArticleDOI

Innate Immune Recognition

TL;DR: Microbial recognition by Toll-like receptors helps to direct adaptive immune responses to antigens derived from microbial pathogens to distinguish infectious nonself from noninfectious self.
Journal ArticleDOI

Inflammation, Atherosclerosis, and Coronary Artery Disease

TL;DR: The evidence is recounted that atherosclerosis, the main cause of CAD, is an inflammatory disease in which immune mechanisms interact with metabolic risk factors to initiate, propagate, and activate lesions in the arterial tree.
Journal ArticleDOI

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

TL;DR: It is shown that mammalian TLR3 recognizes dsRNA, and that activation of the receptor induces the activation of NF-κB and the production of type I interferons (IFNs).
Journal ArticleDOI

Toll-like receptors.

TL;DR: This unit discusses mammalian Toll receptors (TLR1‐10) that have an essential role in the innate immune recognition of microorganisms and are discussed are TLR‐mediated signaling pathways and antibodies that are available to detect specific TLRs.
Related Papers (5)